KH176 under development for rare mitochondrial disease: a first in man randomized controlled clinical trial in healthy male volunteers

BACKGROUND: Mitochondrial disorders are a clinically, biochemically and genetically heterogeneous group of multi-system diseases, with an unmet medical need for treatment. KH176 is an orally bio-available small molecule under development for the treatment of mitochondrial(−related) diseases. The com...

Descripción completa

Detalles Bibliográficos
Autores principales: Koene, Saskia, Spaans, Edwin, Van Bortel, Luc, Van Lancker, Griet, Delafontaine, Brant, Badilini, Fabio, Beyrath, Julien, Smeitink, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644106/
https://www.ncbi.nlm.nih.gov/pubmed/29037240
http://dx.doi.org/10.1186/s13023-017-0715-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644106/
https://www.ncbi.nlm.nih.gov/pubmed/29037240
http://dx.doi.org/10.1186/s13023-017-0715-0

Ejemplares similares